Literature DB >> 12095978

Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer.

Yoshinori Shirota1, Wataru Ichikawa, Hiroyuki Uetake, Hiroyuki Yamada, Zenro Nihei, Kenichi Sugihara.   

Abstract

BACKGROUND: Determination of intratumoral dihydropyrimidine dehydrogenase (DPD) is of clinical interest because increased DPD levels can influence the tumor response to 5-fluorouracil-based chemotherapy through increased inactivation of the agent in tumor cells.
METHODS: DPD messenger RNA (mRNA) levels were evaluated in 80 consecutive patients undergoing surgery for primary colorectal cancer and 12 cases of liver metastasis.
RESULTS: Higher DPD mRNA levels were associated with higher pathologic classification, corresponding to the T categories (r =.267; P =.003). The DPD mRNA level was statistically higher in tumors with microscopic lymph node metastasis than in those without (P =.002). Hence, the DPD mRNA level increased in accordance with Dukes' classification (r =.387; P =.0001). The DPD mRNA level of the liver metastasis from colorectal cancer was significantly higher than that of primary lesions (P =.002). In eight patients, the DPD mRNA level of the liver metastasis was significantly higher than that of the matched primary tumor (P =.017).
CONCLUSIONS: Increases of the DPD mRNA level in cancerous tissue seem to reflect tumor progression. High DPD mRNA levels in liver metastasis and advanced colorectal cancer may have clinical importance for 5-fluorouracil-based chemosensitivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095978     DOI: 10.1007/bf02573898

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.

Authors:  Nisana Tepsiri; Liengchai Chaturat; Banchob Sripa; Wises Namwat; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Wichittra Tassaneeyakul
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

2.  Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.

Authors:  Jun Han; Long-Fei Rong; Chuan-Bin Shi; Xiao-Gang Dong; Jie Wang; Bao-Lin Wang; Hao Wen; Zhen-Yu He
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  Thymidylate synthetase and dihydropyrimidine dehydrogenase mRNA levels in esophageal cancer.

Authors:  Masahiro Kimura; Yoshiyuki Kuwabara; Akira Mitsui; Hideyuki Ishiguro; Nobuyoshi Sugito; Tatsuya Tanaka; Midori Shiozaki; Yasuhiro Naganawa; Hiromitsu Takeyama
Journal:  Oncol Lett       Date:  2010-12-16       Impact factor: 2.967

Review 4.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

5.  Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression.

Authors:  Avo Artinyan; Rahila Essani; Jeffrey Lake; Andreas M Kaiser; Peter Vukasin; Peter Danenberg; Kathleen Danenberg; Robert Haile; Robert W Beart
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

6.  Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

Authors:  W Ichikawa; H Uetake; Y Shirota; H Yamada; T Takahashi; Z Nihei; K Sugihara; Y Sasaki; R Hirayama
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.